MetaCap

China Pharma Holdings Inc. (CPHI)

NYSE: CPHIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.4384-0.0655 (-13.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CPHI stock chart

Technical analysis

Key statistics

All statistics
Market cap
$18.86M
EPS (TTM)
-$0.42
52-week range
0.38 – 19.19
Day range
0.4384 – 0.4852
Volume / Avg
32.83K / 1.60M
Beta
—

52-week range

$0.38$19.19

CPHI stock today

On Nov 20, CPHI ended the session at $0.4384, shedding $0.0655 (13.00%), versus the S&P 500's 3.70% decline. Trading was light, with 32.83K shares changing hands, about 2% of the average daily volume. At this level, CPHI sits near the bottom of its 52-week range of $0.38 to $19.19: 97.7% below the high, set on Jul 21, 2026 and 15.4% above the low.

CPHI is down 63.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 72.6%. China Pharma has posted a net loss over the last twelve months (EPS of -$0.42), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About China Pharma

Company profile

China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Ms. Zhilin Li
Headquarters
Haikou
Employees
215

Financial highlights

Full financials

In fiscal 2025, China Pharma generated $4.1 million in revenue, down 8.5% from fiscal 2024, its first annual decline since 2024. China Pharma reported a net loss of $3.2 million, compared with a loss of $4.7 million a year earlier. Gross margin was -3.2% (up from -43.8%) and operating margin -78.2%.

China Pharma annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$4.14M$4.53M$7.01M$8.10M$9.64M
Growth-8.49%-35.41%-13.48%-15.95%-11.27%
Net income$-3.19M$-4.74M$-3.08M$-3.97M$-3.40M
EPS (diluted)$-0.74$-2.71$-0.91$-3.78$-0.74

Earnings

Earnings history
Last reported (Sep/2026)
Nov 18, 2026
EPS actual vs est.
$-0.17 vs —

China Pharma peers

Health Care sector
CPHI peer companies
CompanyPrice% ChgMarket capCompare
COCPCocrystal Pharma Inc.0.95-2.05%$18.30Mvs CPHI
MRKRMarker Therapeutics Inc.1.09-17.42%$18.17Mvs CPHI
IGCIGC Pharma Inc.0.168-8.70%$19.60Mvs CPHI
TXMDTherapeuticsMD Inc.1.71-5.52%$19.79Mvs CPHI
ACETAdicet Bio Inc.2.14-13.01%$20.03Mvs CPHI
RNAZTransCode Therapeutics Inc.1.16-10.77%$20.07Mvs CPHI
KTTAPasithea Therapeutics Corp.0.4787-0.48%$17.59Mvs CPHI
AARDAardvark Therapeutics Inc.0.9226-7.74%$20.20Mvs CPHI

Indexes, lists and sector

China Pharma stock FAQ

What is China Pharma's stock price today?

CPHI last traded at $0.4384 as of Nov 20, 4:00 PM EST, down 13.00% on the day. Prices are delayed at least 15 minutes.

Does China Pharma pay a dividend?

No. China Pharma does not currently pay a regular cash dividend.

Who is China Pharma's CEO?

Ms. Zhilin Li is the chief executive officer of China Pharma Holdings Inc., which has about 215 employees.

Has CPHI ever split its stock?

Yes. The most recent CPHI stock split was a 1-for-10 split on Apr 15, 2025, one of 4 splits on record.

What is the CPHI 52-week high?

The 52-week high for CPHI is $19.19 and the 52-week low is $0.38. The stock is currently 97.7% below its high.

Compare CPHI